NGVT
BEARISH
$76.19
Live
Ingevity Corporation · NYSE
Target $80.5
(+5.7%)
$33.71
52W Range
$77.62
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated May 01, 2026
Market cap
$2.68B
P/E
N/A
ROE
-133.7%
Profit margin
-14.3%
Debt/Equity
41.84
Dividend yield
N/A
AI Analysis
AI-powered fundamental assessment
Confidence
90%
NGVT exhibits severe fundamental distress, highlighted by a weak Piotroski F-Score of 2/9 and an alarming Debt/Equity ratio of 41.84. Despite a 131% increase in share price over the last year, the company's core financials are deteriorating with negative ROE (-133.66%) and shrinking revenue (-14.60%). There is a massive divergence between the bullish price action and the catastrophic balance sheet, suggesting the current valuation is speculative rather than data-driven.
Key Strengths
Strong 1-year price momentum (+131%)
Positive operating margin (15.21%)
Healthy gross margin (39.53%)
Analyst consensus remains a 'Buy' with a target of $80.50
Current ratio (1.33) indicates short-term liquidity is still intact
Key Risks
Extreme leverage with Debt/Equity at 41.84
Severe valuation disconnect with a Price/Book ratio of 91.03
Negative net profit margins (-14.31%) and collapsing ROE
Negative revenue growth trends (YoY and Q/Q)
Massive earnings miss in the most recent quarter (Actual $-2.37 vs Est $0.65)
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
14
Weak
10
15
40
5
0
AI Verdict
High Risk / Speculative
Key drivers: Piotroski F-Score 2/9, Debt/Equity 41.84, P/B 91.03, Negative Revenue Growth
Confidence
95%
Value
10/100
P/B ratio is an extreme outlier, indicating the stock is trading at a massive premium to its assets.
Positives
- Forward P/E of 12.86 appears low
Watchpoints
- Price/Book of 91.03 is extreme
- PEG ratio of 2.41 suggests overvaluation relative to growth
Future
15/100
Growth metrics are trending sharply downward across all primary indicators.
Positives
- Analyst target price slightly above current price
Watchpoints
- Revenue growth is negative (-14.60%)
- EPS growth is crashing (-349.5% YoY)
Past
40/100
Past price performance is decoupled from past earnings quality.
Positives
- Exceptional 1-year price return
- History of beating estimates in previous years
Watchpoints
- Recent quarterly surprise is deeply negative (-464.6%)
Health
5/100
The balance sheet is in a critical state with unsustainable leverage.
Positives
- Current ratio > 1.0
Watchpoints
- Piotroski F-Score 2/9 (Weak)
- Debt/Equity 41.84
- ROE -133.66%
Dividend
0/100
Company provides no income return to shareholders.
Positives
No standout positives identified.
Watchpoints
- No dividend paid
- 0/100 dividend strength
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$76.19
Analyst Target
$80.5
Upside/Downside
+5.7%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for NGVT and closest competitors.
Updated 2026-04-30
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
NGVT
Ingevity Corporation
Primary
|
-7.2% | +6.4% | +131.0% | +42.4% | +7.0% | +1.2% |
|
DRD
DRDGOLD Limited
Peer
|
+229.9% | +188.5% | +93.0% | +16.9% | +4.4% | -9.1% |
|
ERO
Ero Copper Corp.
Peer
|
+42.2% | +44.3% | +115.7% | +31.4% | +7.5% | -5.7% |
|
EXK
Endeavour Silver Corp.
Peer
|
+69.9% | +138.9% | +155.3% | +19.3% | +5.1% | -5.2% |
|
KALU
Kaiser Aluminum Corporation
Peer
|
+65.6% | +172.3% | +195.9% | +94.9% | +37.5% | +7.5% |
NGV
Ingevity Corporation
Primary
5Y
-7.2%
3Y
+6.4%
1Y
+131.0%
6M
+42.4%
1M
+7.0%
1W
+1.2%
DRD
DRDGOLD Limited
Peer
5Y
+229.9%
3Y
+188.5%
1Y
+93.0%
6M
+16.9%
1M
+4.4%
1W
-9.1%
ERO
Ero Copper Corp.
Peer
5Y
+42.2%
3Y
+44.3%
1Y
+115.7%
6M
+31.4%
1M
+7.5%
1W
-5.7%
EXK
Endeavour Silver Corp.
Peer
5Y
+69.9%
3Y
+138.9%
1Y
+155.3%
6M
+19.3%
1M
+5.1%
1W
-5.2%
KAL
Kaiser Aluminum Corporation
Peer
5Y
+65.6%
3Y
+172.3%
1Y
+195.9%
6M
+94.9%
1M
+37.5%
1W
+7.5%
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
N/A
Forward P/E
12.86
PEG Ratio
2.41
P/B Ratio
91.03
P/S Ratio
2.3
EV/Revenue
3.3
EV/EBITDA
10.76
Market Cap
$2.68B
Profitability
Profit margins and return metrics
Profit Margin
-14.31%
Operating Margin
15.21%
Gross Margin
39.53%
ROE
-133.66%
ROA
8.91%
Growth
Revenue and earnings growth rates
Revenue Growth
-14.6%
Earnings Growth
N/A
Q/Q Revenue Growth
-14.63%
Q/Q Earnings Growth
N/A
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
41.84
High debt
Current Ratio
1.33
Good
Quick Ratio
0.69
Poor
Cash/Share
$2.21
Financial Statement Flow
Interactive flow visualization showing how money moves through the company Q4 2025
Revenue
$0.3B
Gross Margin
34.4%
Op. Margin
15.2%
Net Margin
-33.2%
Total Assets
$1.7B
Liabilities
$1.6B
Equity
$0.0B
Debt/Equity
54.59x
Operating CF
$0.1B
CapEx
$-0.0B
Free Cash Flow
$0.1B
FCF Yield
76%
Quarterly Earnings History
EPS performance vs analyst estimates
2026-05-06
$N/A
2026-02-25
$-2.37
-464.6% surprise
2025-11-05
$1.52
+13.0% surprise
2025-08-04
$1.39
+19.6% surprise
Basic Materials Sector Comparison
Comparing NGVT against 175 companies in the Basic Materials sector
(19 bullish, 68 neutral, 88 bearish)
Return on Equity (ROE)
-133.66%
This Stock
vs
-5.63%
Sector Avg
+2275.2%
(Excellent)
Profit Margin
-14.31%
This Stock
vs
-4.07%
Sector Avg
+251.6%
(Superior)
Debt to Equity
41.84
This Stock
vs
1.09
Sector Avg
+3742.0%
(Higher)
Revenue Growth
-14.6%
This Stock
vs
36.54%
Sector Avg
-140.0%
(Slower)
Current Ratio
1.33
This Stock
vs
4.66
Sector Avg
-71.4%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
NGVT
Ingevity Corporation
|
BEARISH | $2.68B | - | -133.7% | -14.3% | $76.19 | |
|
DRD
DRDGOLD Limited
|
BULLISH | $2.53B | 18.55 | 34.7% | 35.1% | $29.13 | Compare |
|
ERO
Ero Copper Corp.
|
BULLISH | $2.85B | 10.79 | 34.9% | 33.6% | $27.31 | Compare |
|
EXK
Endeavour Silver Corp.
|
NEUTRAL | $2.86B | - | -22.4% | -25.5% | $9.65 | Compare |
|
KALU
Kaiser Aluminum Corporation
|
NEUTRAL | $2.48B | 22.67 | 14.3% | 3.3% | $153.22 | Compare |
NGVT
Ingevity Corporation
BEARISH
Mkt Cap
$2.7B
P/E
-
ROE
-133.7%
Price
$76.19
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-01 | WILLIS JOHN KEVIN | Director | Stock Award | 398 | $28,767 |
| 2026-04-01 | SEGAL FRANCIS DAVID | Director | Stock Award | 329 | $23,780 |
| 2026-02-27 | LI DAVID H | Chief Executive Officer | Stock Award | 38,179 | - |
| 2026-02-27 | DYER TERRANCE M. | Officer | Stock Award | 3,621 | - |
| 2026-02-27 | PLATT PHILLIP JOHN | Officer | Stock Award | 2,108 | - |
| 2026-02-27 | FISHER RYAN C. | General Counsel | Stock Award | 4,442 | - |
| 2026-02-27 | SHUKOV MICHAEL N | Officer | Stock Award | 1,389 | - |
| 2026-02-27 | CASTILLO RUTH | Officer | Stock Award | 3,688 | - |
| 2026-02-27 | CLONTZ CLARENCE REID JR. | Officer | Stock Award | 2,343 | - |
| 2026-02-26 | HALL MARY DEAN | Chief Financial Officer | Stock Award | 1,780 | - |
| 2026-02-26 | PLATT PHILLIP JOHN | Officer | Stock Award | 247 | - |
| 2026-02-26 | WHITE RICHARD ALLEN JR. | Officer | Stock Award | 1,634 | $30,324 |
| 2026-02-26 | FISHER RYAN C. | General Counsel | Stock Award | 192 | - |
| 2026-02-26 | CLONTZ CLARENCE REID JR. | Officer | Stock Award | 187 | - |
| 2026-01-02 | WILLIS JOHN KEVIN | Director | Stock Award | 479 | $28,783 |
WILLIS JOHN KEVIN
Director
2026-04-01
398 shares
·
$28,767
SEGAL FRANCIS DAVID
Director
2026-04-01
329 shares
·
$23,780
LI DAVID H
Chief Executive Officer
2026-02-27
38,179 shares
DYER TERRANCE M.
Officer
2026-02-27
3,621 shares
PLATT PHILLIP JOHN
Officer
2026-02-27
2,108 shares
FISHER RYAN C.
General Counsel
2026-02-27
4,442 shares
SHUKOV MICHAEL N
Officer
2026-02-27
1,389 shares
CASTILLO RUTH
Officer
2026-02-27
3,688 shares
CLONTZ CLARENCE REID JR.
Officer
2026-02-27
2,343 shares
HALL MARY DEAN
Chief Financial Officer
2026-02-26
1,780 shares
PLATT PHILLIP JOHN
Officer
2026-02-26
247 shares
WHITE RICHARD ALLEN JR.
Officer
2026-02-26
1,634 shares
·
$30,324
FISHER RYAN C.
General Counsel
2026-02-26
192 shares
CLONTZ CLARENCE REID JR.
Officer
2026-02-26
187 shares
WILLIS JOHN KEVIN
Director
2026-01-02
479 shares
·
$28,783
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
4 analysts
Wells Fargo
2026-02-27
Equal-Weight
Equal-Weight
Wells Fargo
2026-01-29
Equal-Weight
Equal-Weight
Wells Fargo
2025-12-19
Equal-Weight
Equal-Weight
BMO Capital
2025-12-10
Outperform
Outperform
Wells Fargo
2025-11-12
Equal-Weight
Equal-Weight
Past News Coverage
Recent headlines mentioning NGVT from our newsroom.
Newest → oldest
No matching news yet.